A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities

被引：10
|
作者：
Liao, Xuemei [1 ]
Ye, Hui [2 ]
Si, Tianmei [1 ]
机构：
[1] Peking Univ, Peking Univ Sixth Hosp, Natl Clin Res Ctr Mental Disorders, NHC Key Lab Mental Hlth,Inst Mental Hlth, Huayuanbeilu 51, Beijing 100191, Peoples R China
[2] Sanofi, Dept Med, Shanghai, Peoples R China
来源：
NEUROPSYCHIATRIC DISEASE AND TREATMENT | 2021年 / 17卷
基金：
国家重点研发计划;
关键词：
antipsychotics; switch; metabolic syndrome; INDUCED WEIGHT-GAIN; DOUBLE-BLIND; LONG-TERM; ATYPICAL ANTIPSYCHOTICS; BIPOLAR DISORDER; DRUG TREATMENT; ARIPIPRAZOLE; OLANZAPINE; RISK; PREVALENCE;
D O I：
10.2147/NDT.S294521
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Metabolic syndrome (MetS) in patients with schizophrenia occurs 2-3 times more frequently than in the general population. Antipsychotic medication is a primary risk factor for patients with MetS. In particular, the widely used second-generation antipsychotics can affect glucose and lipid metabolism and can induce insulin resistance and other metabolic abnormalities through various receptors. Notably, the metabolic risks of various anti psychotics may differ because of their different pharmacological affinity to MetS-related receptors. Several previous studies have shown that switching from high to low metabolic risk antipsychotics may improve patients' metabolic parameters. The current review aims to discuss the strategies for switching antipsychotic medications and the impact on metabolic abnormalities in patients with schizophrenia.
引用
收藏
页码：453 / 469
页数：17
相关论文
共 50 条
  • [21] Effect of Comorbid Metabolic Syndrome and Related Components on Cognition in Patients with Schizophrenia
    Celikbas, Zekiye
    Yildiz, Mesut
    Batmaz, Sedat
    Alkar, Ozden Yalcinkaya
    Kocakaya, Hanife
    PSYCHIATRY AND BEHAVIORAL SCIENCES, 2018, 8 (04): : 147 - 157
  • [22] Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study
    Wani, Rayees Ahmad
    Dar, Mansoor Ahmad
    Chandel, Rajesh Kumar
    Rather, Yasir Hassan
    Haq, Inaamul
    Hussain, Arshad
    Malla, Altaf Ahmad
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 685 - 693
  • [23] Schizophrenia: effects of aripiprazole in metabolic syndrome
    Coelho da Silva, Deborah Galvao
    Sales Kanazawa, Luiz Kae
    Dalla Vecchia, Debora
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 55
  • [24] Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders-A Systematic Review and Meta-Analysis
    Mitchell, Alex J.
    Vancampfort, Davy
    Sweers, Kim
    van Winkel, Ruud
    Yu, Weiping
    De Hert, Marc
    SCHIZOPHRENIA BULLETIN, 2013, 39 (02) : 306 - 318
  • [25] The Prevalence of Metabolic Syndrome in Patients with Schizophrenia
    Pavlovic, M.
    Babic, D.
    Rastovic, P.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [26] A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia
    Malhotra, Nidhi
    Kulhara, Parmanand
    Chakrabarti, Subho
    Grover, Sandeep
    JOURNAL OF AFFECTIVE DISORDERS, 2013, 150 (02) : 653 - 658
  • [27] Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia
    Said, Mas Ayu
    Hatim, A.
    Habil, M. H.
    Zafidah, Wan
    Haslina, M. Y.
    Badiah, Y.
    Ramli, M. A.
    Ananjit, S.
    Sapini, Y.
    Shah, Mohd
    Mahmud, Badli
    Bulgiba, Awang
    Hairi, Noran N.
    PREVENTIVE MEDICINE, 2013, 57 : S50 - S53
  • [28] Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan
    Huang, M. -C.
    Lu, M. -L.
    Tsai, C. -J.
    Chen, P. -Y.
    Chiu, C. -C.
    Jian, D. -L.
    Lin, K. -M.
    Chen, C. -H.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 120 (04) : 274 - 280
  • [29] Prevalence and determinants of metabolic syndrome in patients with schizophrenia: A systematic review and meta-analysis of Indian studies
    Ganesh, Suhas
    Ashok, Abhishekh Hulegar
    Kumar, Chennaveerachari Naveen
    Thirthalli, Jagadish
    ASIAN JOURNAL OF PSYCHIATRY, 2016, 22 : 86 - 92
  • [30] The relationship between metabolic syndrome and vitamin D levels in patients with schizophrenia
    Demirkol, Mehmet Emin
    Tamam, Lut
    Cakmak, Soner
    Yesiloglu, Caner
    CUKUROVA MEDICAL JOURNAL, 2019, 44 (03): : 1110 - 1117
12345